News
-
-
PRESS RELEASE
EQS-Adhoc: Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München: Munich Re reports quarterly net profit of €1.7bn and raises full-year guidance
Munich Re reports quarterly net profit of €1.7bn, exceeding estimates and raises full-year guidance. Strong financial performance -
-
-
PRESS RELEASE
Hi3D V1.0 Goes Open Source: The First Production-Validated Open-Source AI 3D Model
Hi3D V1.0, a production-validated open-source AI 3D model, is now available for developers, researchers, and enterprises. It offers high-resolution 3D geometry modeling and advanced features for real-world workflows -
PRESS RELEASE
Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research reaffirms Buy rating on Pharming Group NV with a target price of €2.20 following the Q3 pre-announcement results, showing a 14% y-o-y increase in Ruconest sales. Full report to be released on 27 October -
-
-
PRESS RELEASE
EssilorLuxottica annonce le relèvement à A+ de sa note S&P Global Ratings
EssilorLuxottica annonce le relèvement à A+ de sa note S&P Global Ratings pour refléter sa croissance organique, son flux de trésorerie solide et son orientation stratégique vers la santé visuelle et la med-tech. Pour plus d'informations, consultez le communiqué de presse de S&P Global Ratings -
![Logo of [UNKNOWN]](https://logos.symex.be/img/.jpg)
